Success Metrics

Clinical Success Rate
63.6%

Based on 7 completed trials

Completion Rate
64%(7/11)
Active Trials
1(8%)
Results Posted
57%(4 trials)
Terminated
4(33%)

Phase Distribution

Ph phase_1
5
42%
Ph phase_2
7
58%

Phase Distribution

5

Early Stage

7

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
5(41.7%)
Phase 2Efficacy & side effects
7(58.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

63.6%

7 of 11 finished

Non-Completion Rate

36.4%

4 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(7)
Terminated(4)

Detailed Status

Completed7
Terminated4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
63.6%
Most Advanced
Phase 2

Trials by Phase

Phase 15 (41.7%)
Phase 27 (58.3%)

Trials by Status

active_not_recruiting18%
completed758%
terminated433%

Recent Activity

1 active trials
Showing 5 of 12
active_not_recruitingphase_1

Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

NCT03278925
completedphase_2

Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer

NCT00666562
terminatedphase_2

Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer

NCT01606124
completedphase_2

Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia

NCT00303823
terminatedphase_2

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

NCT00942422
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT03278925Phase 1

Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

Active Not Recruiting
NCT00666562Phase 2

Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer

Completed
NCT01606124Phase 2

Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer

Terminated
NCT00303823Phase 2

Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia

Completed
NCT00942422Phase 2

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

Terminated
NCT00459407Phase 1

Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate

Completed
NCT00516243Phase 1

Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer

Completed
NCT00233935Phase 1

Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus

Completed
NCT01340599Phase 2

Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery

Terminated
NCT00611650Phase 2

Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia

Terminated
NCT00573885Phase 2

Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum

Completed
NCT00091325Phase 1

Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12